Mundelein, IL, United States of America

Yu Cheng

This inventor holds 1 USPTO granted patent. Top assignee: Abbott Laboratories Corporation. Active years: 2012.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Yu Cheng. Retrieved from https://idiyas.com/inventor/yu-cheng-klqt53jd

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2012

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Yu Cheng - Innovator in Diagnostic Assays

Introduction

Yu Cheng is a notable inventor based in Mundelein, IL (US). He has made significant contributions to the field of diagnostics through his innovative work. His expertise lies in the development of peptides that can be utilized for testing the presence of antibodies.

Latest Patents

Yu Cheng holds 1 patent related to his invention. The patent focuses on one or more peptides selected based on the strength and specificity of the human antibody response. These peptides can be used individually or in combination for various applications, including as components of diagnostic assays or kits.

Career Highlights

Yu Cheng is associated with Abbott Laboratories Corporation, a leading company in the healthcare sector. His work at Abbott has allowed him to contribute to advancements in diagnostic technologies.

Collaborations

Some of Yu Cheng's coworkers include Larry G Birkenmeyer and Suresh M Desai. Their collaboration has likely fostered an environment of innovation and development in their projects.

Conclusion

Yu Cheng's contributions to the field of diagnostics through his patented peptides highlight his role as an innovator. His work continues to impact the healthcare industry positively.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…